Winston & Strawn

Site Search

Professionals (266)
Capabilities (77)
Experience (10)
Insights & News (2,224)
Other Results (109)

Professionals 266 results

Monica Lopez-Rodriguez

Of Counsel

Miami

+1 305-910-0501

vCard

Of Counsel

Miami

Yulia Makarova

Partner of Winston & Strawn London LLP

London

+44 20 7011 8803

vCard

Partner of Winston & Strawn London LLP

London

Alessandra Swanson

Partner

Chicago

+1 312-558-7435

vCard

Partner

Chicago

View All Professionals

Capabilities 77 results

Practice Area

Financial Innovation & Regulation

Winston’s Financial Innovation & Regulation attorneys routinely counsel financial services, digital assets, and other clients on complex banking, crypto, FinTech, consumer financial, and securities matters. Many of our team members previously held positions as in-house counsel at global financial institutions and served in positions at government agencies, which gives us considerable experience in helping our clients obtain innovative, effective, and efficient solutions....Read more

Practice Area

Privacy: Regulated Personal Information (RPI)

Winston’s Regulated Personal Information (RPI) Practice offers seamlessly integrated counseling and litigation services to companies looking for practical and solution-oriented assistance navigating the compliance, regulatory, and private class action enforcement risks presented by the emerging patchwork of complex (and often conflicting) privacy laws in the United States and beyond....Read more

Practice Area

Corporate Governance

Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies....Read more

Experience 10 results

Experience

March 18, 2025

Winston Blunts Earnout Payment

Following a bench trial in Fall 2024, a New York trial court ruled in March 2025 that Cresco Labs, Inc. was not required to pay a US$45M earnout under a merger agreement. The court found that Cresco did not receive “commercially reasonable access” to New York’s adult-use cannabis market, which was supposed to be subject only to a non-competitive application or approval process. Adopting Cresco’s arguments, the court determined that only the Office of Cannabis Management and Cannabis Control Board could decide when and how applicants access the adult-use market. The court agreed that regulators required Cresco to pay a significant one-time fee, prioritized other applicants, and had broad discretion over approvals. This win supports claims that New York’s adult-use program lacks details and clear entry paths, frustrating industry leaders’ efforts to develop a robust adult-use market....Read more

Experience

February 10, 2025

US$600 million Total Play Telecomunicaciones S.A.P.I. de C.V. Offer to Exchange Senior Notes

Winston & Strawn represented Total Play Telecomunicaciones, S.A.P.I. de C.V. (“Total Play”), a leading telecommunications company in Mexico, in connection with the offer to exchange (a) up to US$600M of its outstanding 6.375% Senior Notes due 2028 (the “Existing Notes”) for newly issued 11.125% Senior Secured Notes due 2032 (the “New Notes”) and (b) a cash payment by each tendering holder of U.S.$450 for each U.S.$1,000 in Existing Notes tendered by such holder (the “New Money Deposits”) for newly issued New Notes. Total Play also solicited holders for their consent to certain proposed amendments to the Existing Notes. The issuance of the New Notes was issued pursuant to Rule 144A under the Securities Act and outside the United States pursuant to Regulation S under the Securities Act....Read more

Experience

May 10, 2024

Winston Establishes the Enforceability of Keepwell Bonds in Significant Hong Kong Court of Appeal Victory

Winston’s London Restructuring practice scores a significant win on appeal for Hong Kong and BVI liquidator claimants in the People’s Republic of China (PRC) based Peking University Founders Group Limited (PUFG) insolvency. ...Read more

View All Experience

Insights & News 2,224 results

Winston’s AI Top 10

October 2025

5 Min Read

Winston’s AI Monthly Recap - October 2025

Winston’s AI Top 10 summarizes the latest AI developments in the legal industry.

Winston’s Environmental Law Update

October 30, 2025

4 Min Read

E15 Gasoline: Legal Landscape and Recent Legislative Updates

The EPA establishes a national standard for gasoline volatility (Reid vapor pressure, or RVP) via section 211(h) of the Clean Air Act to reduce emissions of volatile organic compounds.

Client Alert

October 29, 2025

7 Min Read

How Do the Florida Office of Financial Regulation’s Proposed Anti-Debanking Rule Revisions Impact Financial Institutions That Operate in Florida?

On October 14, 2025, the Florida Office of Financial Regulation (OFR) published a notice of proposed rulemaking (Notice) to amend certain of its existing anti-debanking rules that implement Florida House Bill 989 (HB 989), which became effective July 1, 2024, and amended Section 655.0323 of the Florida Statutes. If adopted into final form, the proposed amendments would amend Florida Administrative Code Rule 69U-100.323 (Annual Attestation of Compliance) and Rule 69U-100.3231 (Complaint Process Rule).

View All Insights & News

Other Results 109 results

Law Glossary

What Is the FDA?

The FDA stands for the Food and Drug Administration. It is a federal agency charged with protecting the public by regulating the safety and security of drugs, biological products, veterinary medications, and medical devices. FDA responsibilities also cover the safety of: foods for U.S. consumers, cosmetics, animal feed, and radiation-emitting products. Various rules may be established and enforced by the agency in response to U.S. laws or presidential executive orders....Read more

Law Glossary

What Is the Standard for the FDA to Grant a Biosimilar License?

Granting a Biosimilar License...Read more

Law Glossary

What Is the Standard for the FDA to Grant a Generic Drug License?

An Abbreviated New Drug Application (ANDA) must contain evidence that the proposed generic drug product is bioequivalent to the reference drug....Read more